Kaya Limited · NSE:KAYA
Kaya — Investor Presentation (November 2023)
22 slides from Kaya's investor presentation, Nov 9, 2023
Slide 1: Kaya Holdings, Inc. - The Sacred Mushroom
Kaya Holdings, Inc. OTCOR:KAYS On track t the first U.S.- a asilaybi Treat TH E S AC E D Cent ted by a U.S. Be bic Corpor USHROO MUSHROOM EXPLORATION COMPANY ~DIMENSI@N e KAVA HOWINGS © 2028 All Rights Reserved, Kaya Holdings, Inc.
Slide 2: Disclaimer
DISCLAIMER No Offering of Securities No offer is made by this Investor Presentation (this “Presentation”) to invest in Kaya Holdings, Inc. and/or it subsidiaries, including without limitation Fifth Dimension Therapeutics, Inc. (collectively, the “Company) or to purchase any of its and/or their secur
Slide 3: Projected Financial Information
Projected Financial Information Any projected financial information included in this Presentation has been prepared by Company management and is subject to a high degree of uncertainty. It is based upon estimates of future events and circumstances that might or might not ultimately prove to be accur
Slide 4: Quick Stock Facts
SACRED Mesaooy @e KAVA HOWINGS mMiup cAne Kaya Holdings, Inc. (KAYS) Quick Stock Facts Symbol: KAYS SEC Reporting Status: Current Trading Venue: OTCOB Common Shares Outstanding: 22,172,835 Shares in DTC: 8,860,806 12 Month Trading Range: (0.041 - 0.10) © 2023 All Rights Reserved, Kaya Holdings, Inc
Slide 5: Kaya Holdings: a mind care company
wimaay @e KAVA HOWINGS mip CARE Kaya Holdings, Inc (QTCOB:KAYS) is a mind care company focusing on wellness and mental health through operations in medical and recreational cannabis and psychedelic treatment clinics. With over 9 years of continuous retail cannabis operations in Qregon and an interna
Slide 6: Addressing a Mental Healthcare Crisis
JHE af SACRED U HROOM Addressing a Mental Healthcare Crisis Almost 800,000 people commit suicide every year - | every 40 seconds), Medications for chronic mental health conditions fail to provide relief to more than 100 million people. The crisis is overwhelming healthcare systems, emphasizing the n
Slide 7: The Potential Market
a eesey Me waa y The Potential Market “_Psychedelics offer a fundamental change in how mental health disorders are treated...Depression is now one of the leading causes of disability, and the global cost ta treat mental health illness is anticipated to reach $6 trillion by 2030... Many patients simp
Slide 8: Prevalence of mental health disorders
Depression Approximately 9.5% of American adults suffer from a depressive illness each year. {~ Eating Disorders Nearly 8.5 percent of women and 2.5 percent of men have an eating disorder. It is estimated that nearly 30 million people in the United States have an eating disorder. Alcohol & Drug Addi
Slide 9: The Science of Psilocybin
Tet eeseny MusHRooy The Science of Psilocybin (— > Growing evidence suggests that psychedelics act on the brain’s default network, or those regions of the brain that remain active when your brain is not engaged in active tasks. The default network provides a “framework’ for the brain's activity, pro
Slide 10: Problem: No Access to Breakthrough Therapies
a eesey Me waa y Problem: No Access to Breakthrough Therapies Companies such as Compass Pathways, ATAI Life Sciences, and Cybin are engaged in developing synthetic versions of psilocybin and psilocin (the active ingredient in “magic mushrooms") to offer as breakthrough therapies for treatment resist
Slide 11: The Solution
a eesey Me waa y The Solution KAYS, through it's the St Dimension Therapeutics subsidiary, is dedicated to the development and delivery of innovative psychedelics-based mental health therapies that can offer relief immediately. The Sacred Mushroom™ (TSM), currently under development in Portland, Ore
Slide 12: The Facility
JHE. Me SACRED HI EooM The Facility {000 square feet on the top floor of Portland's historic Falcon Building Ab 0 P.O. © 2023 All Rights Reserved, Kaya Holdings, Inc.
Slide 13: © 2023 All Rights Reserved, Kaya Holdings, Inc.
© 2023 All Rights Reserved, Kaya Holdings, Inc.
Slide 14: Facility Features
Facility Features Oo O @ OEY (rp) oa = ap Private rooms for individual Group session areas Activity Zones Microdosing Oh Site 4 massage chairs, listening posts, cultivation Sessions journaling stations, painting and Gale yoga sections The Sacred Mushroom™ is a green oasis 7 floors above the city. Th
Slide 15: Customized Room Options
bea SACRED pieeesy Customized Room Options The Company can customize in-facility room experience by allowing guests to select from options for sight, sound, and scent, Concept Innovations $5 Micro-Dosing Cafe Microdosing psilocybin can be experienced in a café setting, permitting the participant to
Slide 16: Treatment Philosophy
JHE af SACRED Mus HROO 5-4 Accessibility Pricing structures and treatment programs that broaden the base of people able to seek healing through psilocybin. Treatment Philosophy mm (ee Ayo! Sustainability Microdosing and small dosing options for people seeking lower doses as well as those wishing to
Slide 17: The Sacred Mushroom Experience
T « WUSROOM Us The Sacred Mushroom™ Experience Completion of assessment form (online or in-person) to determine suitability for psychedelic treatment. Appointment with a licensed facilitator for medical assessment. Participant selects from proprietary room customization options (changes in a room’s
Slide 18: Treatment Pricing
Tet eeseny MeSHEooM Treatment Pricing A recently published report on psilocybin treatment prices in Oregon showed one facility offering group microdose sessions for $300 (per person) and individual high-dose sessions for $3,500. Another facility first-time full-dose treatments for $15,000.* KAYS exp
Slide 19: Business Model
JHE at SACRED My HROO $e fi wrath BiTa In-Facility Treatments In-facility psilocybin experiences as permitted by law. Business Model gS Integration Services After treatment services and programs to sustain treatment benefits. © 2023 All Rights Reserved, Kaya Holdings, Inc. Pharmaceutical Partnership
Slide 20: Growth Model
JHE af SACRED = Facilities 5t Dimension Therapeutics ™ is working to open additional “The Sacred Mushroom™” psilocybin facilities, as permitted by State laws. Growth Model Supplemental Revenue Streams The Company intends to create additional revenue streams as it develops its client base, including
Slide 21: Conclusion
Conclusion Bringing cutting edge, research supported treatments to people desperately seeking relief. Operating experience in highly regulated environments, Compelling treatment center innovations and experience differentiators. Well positioned for partnerships with select pharmaceutical companies.
Slide 22: Contact
ire SACRED USHROO MUSHROOM EXPLORATION COMPANY “Dimension KAVA HOWINGS An innovative “mind care” subsidiary of KAYS offering research-based therapies to people challenged by treatment resistant mental health disorders. OTCOB:KAYS - Kaya Holdings, Inc. and Subsidiaries W. David Jones Craig Frank Busi
Kaya Holdings — Investor Presentation (November 2023) on 6ix